Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Total operating loss

That $1.3 million would come in handy right now.

I'm more concerned about the draining of PDS's balance sheet

August 31, 2009
May 31, 2009
Cash and cash equivalents
$ 81,419 $ 1,343,582
Licenses receivable
- 6,148,750
Total assets
$ 81,419 $ 7,492,332


August 31, 2009
May 31, 2009
Accounts payable
$ 1,896,242 $ 1,487,799
Members’ equity (deficit)
(1,814,823 ) 6,004,533
Total liabilities and members’ equity (deficit)
$ 81,419 $ 7,492,332

Three Months Ended
August 31,
2009
2008
Revenues
$ 2,327,655 $ 16,275,000
Operating expenses
2,813,664 1,942,560
Operating income (loss)
(486,009 ) 14,332,440
Interest income
307 28,639
Net income (loss)
$ (485,702 ) $ 14,361,079
Share
New Message
Please login to post a reply